Clinical Trials Drug Development Drug Trials Studies Drug Efficacy Translational Medicine Epidemiology Observational Studies Animal Studies Patient Studies
Oncolytic HSV-1 with nivolumab triggered tumor shrinkage or disappearance throughout the body in patients who had not responded to existing immunotherapies.